Tinzaparin failure in a pregnant patient with a mitral metal valve.
Higgins
M
M
Departments of Obstetrics and Gynaecology, UCD School of Medicine and Medical Science, National Maternity Hospital, Dublin, Ireland. mary.higgins@ucd.ie
Downey
R
R
Murphy
K
K
McAuliffe
F
F
D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D013927:Thrombosis / Q000188:drug therapy*; D000078222:Tinzaparin; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin